Wed, May 16, 2018
Tue, May 15, 2018
Mon, May 14, 2018
Fri, May 11, 2018
Thu, May 10, 2018
Wed, May 9, 2018
Tue, May 8, 2018
Mon, May 7, 2018
Fri, May 4, 2018
Thu, May 3, 2018
Wed, May 2, 2018
Tue, May 1, 2018

Stephen Willey Maintained (ALNY) at Hold with Decreased Target to $95 on, May 4th, 2018


//stocks-investing.news-articles.net/content/201 .. with-decreased-target-to-95-on-may-4th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Stephen Willey of Stifel, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Decreased Target from $107 to $95 on, May 4th, 2018.

Stephen has made no other calls on ALNY in the last 4 months.



There are 3 other peers that have a rating on ALNY. Out of the 3 peers that are also analyzing ALNY, 2 agree with Stephen's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Lebovitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $118 on, Friday, February 9th, 2018
  • Paul Matteis of "Leerink Swann" Maintained at Hold with Increased Target to $135 on, Thursday, January 25th, 2018


This is the rating of the analyst that currently disagrees with Stephen


  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $154 on, Tuesday, March 13th, 2018

Publication Contributing Sources